Abstract
IntroductionTransducin (β)-like 1 X-linked receptor 1(TBLR1) is an F-box-like and WD repeat-containing protein which functions as a switch in transcriptional activation, However, the clinical significance and biological role of TBLR1 in breast cancer remains largely unknown.MethodsWestern blotting, immunocytochemistry and real-time PCR were used to evaluate TBLR1 expression in normal breast epithelial cells and breast cancer cell lines, clinical tissue samples and adjacent nontumor tissues, and in 214 paraffin-embedded specimens. Statistical analyses were used to test for the prognostic and diagnostic associations. The biological role of TBLR1 -induced proliferation and tumorigenicity in breast cancer cells was explored in vitro and in vivo. The effect of TBLR1 on the expression of cyclin D1 and β-catenin signaling was examined by Western blotting, luciferase reporter assay and by several immunoprecipitation techniques.ResultsTBLR1 was significantly upregulated in breast cancer cells and tissues compared to normal control samples. Immunohistochemical analysis revealed high expression of TBLR1 in 113 of 214 (52.8%) paraffin-embedded archival breast cancer. The overall expression level of TBLR1 was significantly correlated with clinical stage (P <0.001), the tumor classification (P <0.001), node classification (P =0.024), and metastasis classification (P = 0.004), histological grade (P = 0.044), as well as with the expression level of c-erbB2 (P = 0.036) and Ki-67 (P <0.001). Patients with higher TBLR1 expression had shorter overall survival time, whereas patients with lower TBLR1 expression had better survival. Multivariate analysis suggested that TBLR1 expression might be an independent prognostic indicator for the survival of breast cancer patients. TBLR1 overexpression promoted, whereas TBLR1 silencing inhibited, proliferation and tumorigenicity in breast cancer cells both in vitro and in vivo. We found that TBLR1 expression was implicated in the upregulation of cyclin D1, phosphorylation of cell-cycle control protein Rb (pRb) and activation of β-catenin signaling in breast cancer.ConclusionsTBLR1 plays a key role in the development and progression of breast cancer cells via cyclin D1-transactivation and activation of the β-catenin signaling pathway. TBLR1 may be a novel prognostic marker and a potential therapeutic target in the treatment human breast cancer.Electronic supplementary materialThe online version of this article (doi:10.1186/s13058-014-0465-z) contains supplementary material, which is available to authorized users.
Highlights
Transducin (β)-like 1 X-linked receptor 1(TBLR1) is an F-box-like and WD repeat-containing protein which functions as a switch in transcriptional activation, the clinical significance and biological role of transducin-like 1 X-linked receptor 1 (TBLR1) in breast cancer remains largely unknown
TBLR1 is thought to control the switch from gene repression to gene activation of nuclear receptors and other molecules required for transcriptional activation, including estrogen receptor (ER), androgen receptor (AR), thyroid hormone receptor β (TRβ), peroxisome proliferator-activated receptor γ (PPARγ), nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), Notch and β-catenin [10,11,12,13,14,15,16]
Western blotting and IHC showed that TBLR1 protein was upregulated in breast cancer tissue samples compared to their matched adjacent non-tumor tissues from the same patient (Figure 1B and C); and real-time PCR revealed that TBLR1 mRNA was significantly upregulated in breast cancer tissues (Additional file 1: Figure S1B)
Summary
Transducin (β)-like 1 X-linked receptor 1(TBLR1) is an F-box-like and WD repeat-containing protein which functions as a switch in transcriptional activation, the clinical significance and biological role of TBLR1 in breast cancer remains largely unknown. Transducin (β)-like 1 X-linked receptor (TBLR1) is an F-box/WD-40-containing factor which was initially identified as a component of an SMRT/N-CoR corepressor complex. It is a member of the TBL1 family, which is encoded by a distinct gene located on Chromosome 3 and is highly homologous to the TBL1 protein encoded by the TBL1X gene. Previous studies have shown that TBLR1 is highly expressed in lung squamous cell carcinoma [17], the clinical significance and biological function of TBLR1 in the progression of breast cancer remain to be established
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
